Gunnar Norkrans

Vertically acquired occult hepatitis B virus infection may become overt after several years
Anders Eilard, Maria Andersson, Rune Wejstål, Johan Ringlander, Gunnar Norkrans et al.
Journal of Infection, Artikel i vetenskaplig tidskrift 2019
Artikel i vetenskaplig tidskrift

Management of hepatitis B virus infection, updated Swedish guidelines.
Johan Westin, Soo Aleman, Maria Castedal, Ann-Sofi Duberg, Anders Eilard et al.
Infectious diseases (London, England), Artikel i vetenskaplig tidskrift 2019
Artikel i vetenskaplig tidskrift

Integration of hepatitis B virus DNA in chronically infected patients assessed by Alu-PCR
Simon B. Larsson, Gianluca Tripodi, G. Raimondo, C. Saitta, Gunnar Norkrans et al.
Journal of Medical Virology, Artikel i vetenskaplig tidskrift 2018
Artikel i vetenskaplig tidskrift

High serum levels of pregenomic RNA reflect frequently failing reverse transcription in hepatitis B virus particles
Kasthuri Prakash, Gustaf E Rydell, Simon B. Larsson, Maria Andersson, Gunnar Norkrans et al.
Virology Journal, Artikel i vetenskaplig tidskrift 2018
Artikel i vetenskaplig tidskrift

PRO-C3: a new and more precise collagen marker for liver fibrosis in patients with chronic hepatitis C
J. F. Hansen, M. J. Nielsen, Kristina Nyström, D. J. Leeming, Martin Lagging et al.
Scandinavian Journal of Gastroenterology, Artikel i vetenskaplig tidskrift 2018
Artikel i vetenskaplig tidskrift

Treatment of hepatitis C virus infection: updated Swedish Guidelines 2016.
Martin Lagging, Rune Wejstål, Gunnar Norkrans, Olle Karlström, Soo Aleman et al.
Infectious diseases (London, England), Artikel i vetenskaplig tidskrift 2017
Artikel i vetenskaplig tidskrift

Smaller reduction of hepatitis B virus DNA in liver tissue than in serum in patients losing HBeAg
Gianluca Tripodi, Simon B. Larsson, Gunnar Norkrans, Magnus Lindh
Journal of Medical Virology, Artikel i vetenskaplig tidskrift 2017
Artikel i vetenskaplig tidskrift

Treatment of hepatitis C virus infection for adults and children: Updated Swedish consensus recommendations.
Martin Lagging, Rune Wejstål, Gunnar Norkrans, Olle Karlström, Soo Aleman et al.
Infectious diseases (London, England), Artikel i övriga tidskrifter 2016
Artikel i övriga tidskrifter

Randomized Trial Evaluating the Impact of Ribavirin Mono-Therapy and Double Dosing on Viral Kinetics, Ribavirin Pharmacokinetics and Anemia in Hepatitis C Virus Genotype 1 Infection
Jesper Waldenström, Johan Westin, Kristina Nyström, P. Christensen, O. Dalgard et al.
PLoS ONE, Artikel i vetenskaplig tidskrift 2016
Artikel i vetenskaplig tidskrift

Short interferon and ribavirin treatment for HCV genotype 2 or 3 infection: NORDynamIC trial and real-life experience
Jesper Waldenström, M. Farkkila, Karolina Rembeck, Gunnar Norkrans, N. Langeland et al.
Scandinavian Journal of Gastroenterology, Artikel i vetenskaplig tidskrift 2016
Artikel i vetenskaplig tidskrift

Wider indications for treatment of chronic hepatitis B?
Magnus Lindh, Kristoffer Hellstrand, Gunnar Norkrans
Journal of viral hepatitis, Artikel i vetenskaplig tidskrift 2008
Artikel i vetenskaplig tidskrift

Randomized comparison of 12 or 24 weeks of peginterferon alpha-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection.
Martin Lagging, Nina Langeland, Court Pedersen, Martti Färkkilä, Mads Rauning Buhl et al.
Hepatology (Baltimore, Md.), Artikel i vetenskaplig tidskrift 2008
Artikel i vetenskaplig tidskrift

Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection.
Martin Lagging, Nina Langeland, Court Pedersen, Martti Färkkilä, Mads Rauning Buhl et al.
Hepatology (Baltimore, Md.), Artikel i vetenskaplig tidskrift 2008
Artikel i vetenskaplig tidskrift

Response prediction and treatment tailoring for chronic hepatitis C virus genotype 1 infection
Magnus Lindh, Erik Alestig, Birgitta Arnholm, Anders Eilard, Kristoffer Hellstrand et al.
J Clin Microbiol, Artikel i vetenskaplig tidskrift 2007
Artikel i vetenskaplig tidskrift

Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection
Johan Westin, Martin Lagging, Amar P Dhillon, Gunnar Norkrans, Ana Romero et al.
J Viral Hepat, Artikel i vetenskaplig tidskrift 2007
Artikel i vetenskaplig tidskrift

IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection
Martin Lagging, Ana Romero, Johan Westin, Gunnar Norkrans, Amar P Dhillon et al.
Hepatology, Artikel i vetenskaplig tidskrift 2006
Artikel i vetenskaplig tidskrift

Lamivudine resistance of hepatitis B virus masked by coemergence of mutations in probe region of the COBAS AMPLICOR assay.
Magnus Lindh, Charles Hannoun, Sebastian Malmström, Johan Lindberg, Gunnar Norkrans
Journal of clinical microbiology, Forskningsöversiktsartikel 2006
Forskningsöversiktsartikel

Monitoring treatment response by the hepatitis C virus core antigen assay.
Magnus Lindh, Martin Lagging, Johan Westin, Rune Wejstål, Gunnar Norkrans
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, Forskningsöversiktsartikel 2005
Forskningsöversiktsartikel

Predictive factors and virological response to interferon treatment in children with chronic hepatitis B.
Ann Söderström, Magnus Lindh, Kajsa Ekholm, Nils Conradi, Peter Horal et al.
Scandinavian journal of infectious diseases, Artikel i vetenskaplig tidskrift 2005
Artikel i vetenskaplig tidskrift

Phylogeny of African complete genomes reveals a West African genotype A subtype of hepatitis B virus and relatedness between Somali and Asian A1 sequences.
Charles Hannoun, Ann Söderström, Gunnar Norkrans, Magnus Lindh
The Journal of general virology, Artikel i vetenskaplig tidskrift 2005
Artikel i vetenskaplig tidskrift